• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

specialty

  1. Rheumatology sales - pros and cons?

    Considering an internal transition from a vaccine specialist for adult vaccines to a key account specialist role in rheumatology. I have never worked in the specialty space and know rheumatology is very competitive. My ultimate goal is to gain varied experience in different therapeutic areas but...
  2. Bristol-Myers Squibb swallows Celgene for $74 billion

    Bristol-Myers Squibb acquires Celgene for $74 billion. Celgene stock surges while BMY plunges. 2019 starts well for Celgene. More M&As are in the pipeline in the biopharma space.
  3. Independent Pharmacy Representation

    Anyone heard of independent pharmacies contracting sales reps to sell docs on writing scripts to that pharmacy? Legality? Thoughts?
  4. What division in Medtronic is the least stressful?

    Internet trolls, please stay away. I'm looking for an honest answer. I've been with Medtronic for a year and don't like my division (won't specify). The hours are grueling, I'm constantly go go go. I just want somewhat of a less stressful position, but I like working for the company. What...